Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-18-029578)

Filing Details

Accession Number:: 0001209191-18-029578
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-05-11 16:34:17
Reporting Period:: 2018-05-09

Accepted Time:: 2018-05-11 16:34:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
921299	Fibrogen Inc	FGEN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1621330	Jorma Routti	C/O Fibrogen, Inc. 409 Illinois St. San Francisco CA 94158		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-05-09	6,000	$9.78	133,840	No	4	M	Direct
Common Stock	Disposition	2018-05-09	6,000	$47.10	127,840	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2018-05-09	6,000	$0.00	6,000	$9.78

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,000		2023-04-17	No	4	M	Direct

Footnotes

Shares sold pursuant to a 10b5-1 plan.
The shares were sold at prices ranging from $46.80 to $47.75. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Fully vested.